BlackRock, VanEck among asset managers that submitted updated filings for spot bitcoin ETF

By Suzanne McGee and Hannah Lang (Reuters) – Asset management firms hoping to be among the first to win regulatory approval to launch exchange traded funds (ETFs) tied to the spot price of bitcoin updated their filings with the Securities and Exchange Commission on Thursday and Friday, as market participants said a decision from the…

Read More

Exclusive-Drugmakers set to raise U.S. prices on at least 500 drugs in January

By Michael Erman and Patrick Wingrove NEW YORK (Reuters) -Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors. Excluding different doses and formulations, more than 140 brands of drugs will…

Read More